These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2080516)

  • 1. Distribution and elimination of brevetoxin PbTx-3 in rats.
    Poli MA; Templeton CB; Thompson WL; Hewetson JF
    Toxicon; 1990; 28(8):903-10. PubMed ID: 2080516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake, tissue distribution, and excretion of brevetoxin 3 administered to rats by intratracheal instillation.
    Benson JM; Tischler DL; Baden DG
    J Toxicol Environ Health A; 1999 Jul; 57(5):345-55. PubMed ID: 10405188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution and elimination of ingested brevetoxin (PbTx-3) in rats.
    Cattet M; Geraci JR
    Toxicon; 1993 Nov; 31(11):1483-6. PubMed ID: 8310449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a rapid detoxification mechanism for brevetoxin in rats.
    Radwan FF; Wang Z; Ramsdell JS
    Toxicol Sci; 2005 Jun; 85(2):839-46. PubMed ID: 15746006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue distribution of amino acid- and lipid-brevetoxins after intravenous administration to C57BL/6 mice.
    Leighfield TA; Muha N; Ramsdell JS
    Chem Res Toxicol; 2014 Jul; 27(7):1166-75. PubMed ID: 24949875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake, tissue distribution, and excretion of brevetoxin-3 administered to mice by intratracheal instillation.
    Tibbetts BM; Baden DG; Benson JM
    J Toxicol Environ Health A; 2006 Jul; 69(14):1325-35. PubMed ID: 16760139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brevetoxin: tissue distribution and effect on cytochrome P450 enzymes in fish.
    Washburn BS; Baden DG; Gassman NJ; Walsh PJ
    Toxicon; 1994 Jul; 32(7):799-805. PubMed ID: 7940587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brevetoxin metabolism and elimination in the Eastern oyster (Crassostrea virginica) after controlled exposures to Karenia brevis.
    Plakas SM; Wang Z; El Said KR; Jester EL; Granade HR; Flewelling L; Scott P; Dickey RW
    Toxicon; 2004 Nov; 44(6):677-85. PubMed ID: 15501294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Confirmation of brevetoxin metabolism in the Eastern oyster (Crassostrea virginica) by controlled exposures to pure toxins and to Karenia brevis cultures.
    Plakas SM; el-Said KR; Jester EL; Granade HR; Musser SM; Dickey RW
    Toxicon; 2002 Jun; 40(6):721-9. PubMed ID: 12175608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue uptake, distribution and excretion of brevetoxin-3 after oral and intratracheal exposure in the freshwater turtle Trachemys scripta and the diamondback terrapin Malaclemys terrapin.
    Cocilova CC; Flewelling LJ; Bossart GD; Granholm AA; Milton SL
    Aquat Toxicol; 2017 Jun; 187():29-37. PubMed ID: 28363127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrinsic potency of synthetically prepared brevetoxin cysteine metabolites BTX-B2 and desoxyBTX-B2.
    Dechraoui MY; Wang Z; Ramsdell JS
    Toxicon; 2007 Nov; 50(6):825-34. PubMed ID: 17689582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake and elimination of brevetoxin in blood of striped mullet (Mugil cephalus) after aqueous exposure to Karenia brevis.
    Woofter RT; Brendtro K; Ramsdell JS
    Environ Health Perspect; 2005 Jan; 113(1):11-6. PubMed ID: 15626641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brevetoxin derivatives that inhibit toxin activity.
    Purkerson-Parker SL; Fieber LA; Rein KS; Podona T; Baden DG
    Chem Biol; 2000 Jun; 7(6):385-93. PubMed ID: 10873835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LC/MS analysis of brevetoxin metabolites in the Eastern oyster (Crassostrea virginica).
    Wang Z; Plakas SM; El Said KR; Jester EL; Granade HR; Dickey RW
    Toxicon; 2004 Mar; 43(4):455-65. PubMed ID: 15051410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brevetoxin binding: molecular pharmacology versus immunoassay.
    Baden DG; Mende TJ; Szmant AM; Trainer VL; Edwards RA; Roszell LE
    Toxicon; 1988; 26(1):97-103. PubMed ID: 3347935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complex behavior of marine animal tissue extracts in the competitive binding assay of brevetoxins with rat brain synaptosomes.
    Whitney PL; Delgado JA; Baden DG
    Nat Toxins; 1997; 5(5):193-200. PubMed ID: 9496378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiorespiratory effects of brevetoxin (PbTx-2) in conscious, tethered rats.
    Templeton CB; Poli MA; LeClaire RD
    Toxicon; 1989; 27(9):1043-9. PubMed ID: 2799835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomonitoring brevetoxin exposure in mammals using blood collection cards.
    Fairey ER; Shuart NG; Busman M; Moeller PD; Ramsdell JS
    Environ Health Perspect; 2001 Jul; 109(7):717-20. PubMed ID: 11485871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal transfer and sublethal immune system effects of brevetoxin exposure in nesting loggerhead sea turtles (Caretta caretta) from western Florida.
    Perrault JR; Bauman KD; Greenan TM; Blum PC; Henry MS; Walsh CJ
    Aquat Toxicol; 2016 Nov; 180():131-140. PubMed ID: 27716578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brevetoxin-3 (PbTx-3) on mouse liver slices: a histological study.
    Rodríguez-Rodríguez FA; Maldonado C
    P R Health Sci J; 1996 Dec; 15(4):261-7. PubMed ID: 9097343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.